2026 Trends in Drug Benefit Design Report
PSG announces the results of its extensive research on the latest trends in drug benefit design. Plan sponsors face complex decisions and challenges…
Read Post
Insights
Categories
Topics
Categories
Topics
Carving Out Pharmacy Benefit Solutions: The Changing Landscape of Pharmacy Benefit Management
It is estimated that 6.7 billion prescriptions were dispensed in 2022 [1], while 70% of US adults report taking at least one prescription per…
Read Post
2023 Pharmacy Benefit Manager Customer Satisfaction Report
Overview The PBM Customer Satisfaction Report provides the most in-depth picture of the PBM landscape today. This research prepares plan sponsors and health plans…
Read Post
New Vyvanse Generic: A Break for Employers?
Self-funded employer groups face an overwhelming number of challenges in 2023 and beyond when tasked with controlling pharmacy costs, including an emerging anti-obesity…
Read Post
Survey: Satisfaction With Pharmacy Benefits Managers Hits 9-Year Low
Pharmaceutical Strategies Group’s 26th annual customer satisfaction survey reveals vulnerabilities in PBM sentiment (DALLAS, TX) – Satisfaction with pharmacy benefit managers (PBMs) has plunged…
Read Post
2023 State of Specialty Spend & Trend Report
Specialty drug management remains a top concern for health payers, including managed care organizations and employers. The 2023 State of Specialty Spend and Trend…
Read Post
2023 Trends in Specialty Drug Benefits Report
PSG announces the results of its extensive research on the latest trends in specialty drug benefits. This proprietary research provides detailed intelligence to…
Read Post
State of Specialty Spend and Trend Report Released by Pharmaceutical Strategies Group
Spend and trend rise in 2022 forecasted to continue (DALLAS, TX) – Pharmaceutical Strategies Group (PSG), an EPIC company, is pleased to announce the release…
Read Post
STAT Article Highlights the Importance of Independence in Pharmacy Consulting
If you’re reading anything by PSG, you likely are already aware that the pharmaceutical supply chain is complex and, at times, dysfunctional. Many are…
Read Post
Trends in Drug Benefit Design Report Released by Pharmaceutical Strategies Group
Highlights plan sponsors’ strategies to address changing environment (DALLAS, TX) – Pharmaceutical Strategies Group (PSG), an EPIC company, is pleased to announce the launch…
Read Post
2023 Trends in Benefit Design Report
Pharmaceutical Strategies Group (PSG) is pleased to present the 2023 Trends in Drug Benefit Design Report, which details traditional (non-specialty) drug benefit trends…
Read Post
The Impact of Insulin Price Decreases on Employers
When Eli Lilly announced a 70% price reduction and a $35 cap on insulin prices, it started a chain reaction that…
Read Post